ArticleGut2018
A metabolomics-based biomarker signature discriminates pancreatic cancer from chronic pancreatitis.
Article in Gut, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Lipid metabolic profiling and diagnostic model development for hyperlipidemic acute pancreatitis.Frontiers in physiology · 2024Article
- To metabolomics and beyond: a technological portfolio to investigate cancer metabolism.Signal transduction and targeted therapy · 2023Review
- Nanomaterials-assisted metabolic analysis toward in vitro diagnostics.Exploration (Beijing, China) · 2022Review
- Ruscogenin Alleviates Myocardial Ischemia-Induced Ferroptosis through the Activation of BCAT1/BCAT2.Antioxidants (Basel, Switzerland) · 2022Article
- Dietary and Lifestyle Factors Associated with Gastric and Pancreatic Cancers: A Case-Control Study.Preventive nutrition and food science · 2021Article
- Pancreatic stellate cells regulate branched-chain amino acid metabolism in pancreatic cancer.Annals of translational medicine · 2021Article
- Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer.Cancers · 2020Review
- Novel Metabolomics Serum Biomarkers for Pancreatic Ductal Adenocarcinoma by the Comparison of Pre-, Postoperative and Normal Samples.Journal of Cancer · 2020Article
- Elevated Polyamines in Saliva of Pancreatic Cancer.Cancers · 2018Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
28539352What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.